Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
Sautter-Bihl
M L
ML
Department of Radiooncology, Klinikum Karlsruhe, Germany.
Dörr
U
U
Schilling
F
F
Treuner
J
J
Bihl
H
H
D019797:3-Iodobenzylguanidine; D002872:Chromosome Deletion; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007205:Indium Radioisotopes; D007223:Infant; D007457:Iodine Radioisotopes; D007462:Iodobenzenes / Q000493:pharmacokinetics; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009447:Neuroblastoma / Q000000981:diagnostic imaging* / Q000235:genetics; D015282:Octreotide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D004369:Pentetic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D011003:Ploidies; D011379:Prognosis; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000032:analysis; D015996:Survival Rate
D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D017481:Receptors, Somatostatin; C071632:SDZ 215-811; D019797:3-Iodobenzylguanidine; D004369:Pentetic Acid; D015282:Octreotide